María Lorena Brance

María Lorena Brance

Auto-generated profile, based on publicly available information

María Lorena Brance

Bone Biology Laboratory, School of Medicine, Rosario National University, Rosario, Santa Fe, Argentina

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2023 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
WBWilson Bautista-Molano
Wilson Bautista-Molano
DFDaniel G. Fernández-Ávila
Daniel G. Fernández-Ávila
MBMaría Lorena Brance
María Lorena Brance
MPMaría Gabriela Ávila Pedretti
María Gabriela Ávila Pedretti
RBRuben Burgos-Vargas
Ruben Burgos-Vargas
ESEnrique R. R. Soriano
Enrique R. R. Soriano

4 September 2020 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
MBMaría Lorena Brance
María Lorena Brance
SGSilvana Di Gregorio
Silvana Di Gregorio
BPBernardo A. Pons-Estel
Bernardo A. Pons-Estel
NQNorberto J. Quagliato
Norberto J. Quagliato
MJMarisa Jorfen
Marisa Jorfen
LBLucas R. Brun
Lucas R. Brun
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint deformity and disability, as well as muscle involvement. Sarcopenia is characterized by a progressive age-related loss of muscle mass and strength. Aim: The aim of this study was to evaluate the prevalence of sarcopenia and possible contributing factors associated with sarcopenia in RA patients. Patients and Methods: Adult RA patients (n = 105) of both sexes and 100 subjects as control group (CG) matched by age, sex, and body mass index were included in this cross-sectional study. Whole-body composition was measured by dual-energy x-ray absorptiometry. Sarcopenia was defined according to European Working Group on Sarcopenia in Older People 2 as low muscle strength (handgrip) and low muscle mass (appendicular skeletal muscle mass [ASM] index by dual-energy x-ray absorptiometry). The association between sarcopenia and associated factors was evaluated using logistic regression analyses. Results: Significantly lower percentage of lean mass and ASM were found in the whole RA group compared with controls. However, lower lean parameters (total lean mass, percentage of lean mass, and ASM) were observed only in female subjects. The ASM index was significantly lower in female subjects with RA (RA 31.0% vs CG 11.9%) without differences in male subjects. On the other hand, fat mass and most adipose indices were significantly higher in both female and male subjects with RA. Female RA patients had higher prevalence of sarcopenia and sarcopenic obesity. Through univariate logistic regression analysis, the time of corticosteroids use, cumulative corticosteroid dose, previous fragility fractures, total lean mass, and ASM were associated with sarcopenia. Conclusions: Higher prevalence of sarcopenia and sarcopenic obesity were found in female RA patients. Sarcopenia was found in younger female subjects with RA compared with healthy control subjects. Sarcopenia was associated with previous fragility fractures in female patients with RA.

11 October 2011 in British Journal of Nutrition
Verified
Journal Article
Closed access
LBLucas R. Brun
Lucas R. Brun
MBMaría L. Brance
María L. Brance
ARAlfredo Rigalli
Alfredo Rigalli
Intestinal alkaline phosphatase (IAP) is a brush-border phosphomonoesterase. Its location suggests an involvement in the uptake of nutrients, but its role has not yet been defined. IAP expression parallels that of other proteins involved in Ca absorption under vitamin D stimulation. Experiments carried outin vitrowith purified IAP have demonstrated an interaction between Ca and IAP. The gut is prepared to face different levels of Ca intake over time, but high Ca intake in a situation of a low-Ca diet over time would cause excessive entry of Ca into the enterocytes. The presence of a mechanism to block Ca entry and to avoid possible adverse effects is thus predictable. Thus, in the present study, Sprague–Dawley rats were fed with different amounts of Ca in the diet (0·2, 1 and 2 g%), and the percentage of Ca absorption (%Ca) in the presence and absence ofl-phenylalanine (Phe) was calculated. The presence of Phe caused a significant increase in %Ca (52·3 (sem6·5) % in the presence of Phev. 31·1 (sem8·9) % in the absence of Phe, regardless of the amount of Ca intake; pairedttest,P = 0·02). When data were analysed with respect to Ca intake, a significant difference was found only in the group with low Ca intake (pairedttest,P = 0·03). Additionally, IAP activity increased significantly (ANOVA,P < 0·05) as Ca concentrations increased in the duodenal lumen. The present study providesin vivoevidence that luminal Ca concentration increases the activity of IAP and simultaneously decreases %Ca, acting as a minute-to-minute regulatory mechanism of Ca entry.

1 July 2014 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
MBMaría L. Brance
María L. Brance
LBLucas R. Brun
Lucas R. Brun
SLSusana Lioi
Susana Lioi
ASAriel Sánchez
Ariel Sánchez
MAMarcelo Abdala
Marcelo Abdala
BOBeatriz Oliveri
Beatriz Oliveri

30 July 2015 in Calcified Tissue International
Verified
Journal Article
Open access
PDF file
LBLucas R. Brun
Lucas R. Brun
MBMaría L. Brance
María L. Brance
MLMercedes Lombarte
Mercedes Lombarte
MMMaría Cielo Maher
María Cielo Maher
VLVerónica Elina Di Loreto
Verónica Elina Di Loreto
ARAlfredo Rigalli
Alfredo Rigalli
Yerba mate (Ilex paraguariensis) is a xanthine-containing beverage, which is also rich in caffeine. Because caffeine has a negative impact on bone mineral density (BMD) mainly associated with low calcium (Ca) diets, there would be expected a negative effect of yerba mate on bone. In this study, Sprague-Dawley rats were used and randomly assigned into four groups (n = 6/group): Control + Ca 0.2 g %; Control + Ca 0.9 g %; Yerba + Ca 0.2 g %; Yerba + Ca 0.9 g %. At the end of the experiment, tibias and femurs were obtained for BMD, morphometric, histomorphometric, and biomechanical analyses. While there was no difference in bone parameters between rats with and without yerba mate consumption, a negative effect of low Ca diet was observed in BMD, morphometric, histomorphometric, and biomechanical results. Interaction between Ca content in the diet and yerba mate was only found in trabecular bone volume, which would indicate that the negative effect of low Ca intake on bone volume is reversed in part by yerba mate infusion. However, yerba mate was not able to reverse the negative effect of low Ca content on biomechanical properties and trabecular connectivity. In summary, at least in our study, yerba mate would not have a negative effect on bone and would be safe for the bone health of consumers.

22 April 2014 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
LBLucas R. Brun
Lucas R. Brun
MBMaría L. Brance
María L. Brance
MLMercedes Lombarte
Mercedes Lombarte
MLMaela Lupo
Maela Lupo
VLVerónica E. Di Loreto
Verónica E. Di Loreto
ARAlfredo Rigalli
Alfredo Rigalli